CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2026-03-31 | Twitty Christopher Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2026-03-31 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Charych Deborah H. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Grayson Paul A. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Schwab Andrew J. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +9,194 | 9,194 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −9,194 | 0 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +22,021 | 22,021 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −22,021 | 0 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −8,000 | 0 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +7,080 | 7,080 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −7,080 | 0 |
Page 3 of 15 · 292 trades